POLARSTEM Cementless Hip Stem
- Sponsor
- Smith & Nephew, Inc.
- Study ID
- NCT02648152
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Total Hip Arthroplasty — DEVICETotal Hip Arthroplasty using Cementless version of the POLARSTEM
Study Details
Multicenter observational study to validate that the POLARSTEM™ is a state-of-the-art implant in terms of radiographic, clinical performance and long-term survivorship.
Key Dates
- Start date
- Mar 31, 2009
- Status verified
- Dec 2021
- Primary completion
- Nov 30, 2020
- Completion
- Nov 30, 2020
Study Design
- Enrollment
- 218 participants (actual)
Primary Outcome Measure
Kaplan-Meier Estimate: Overall Survivorship of POLARSTEM [ Time Frame: Pre-operatively, 3 months, 12 months, 36 months, 60 months, and 120 months ]
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the ShoulderPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the KneePHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the HipPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania